Top compounds associated with response to BMI1


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.01
mRNA paclitaxel UHNBreast pan-cancer AAC -0.7 0.01
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.081 0.01
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC -0.084 0.01
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.08 0.02
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.02
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.082 0.02
mRNA azacitidine CTRPv2 pan-cancer AAC 0.088 0.02
mRNA RITA CTRPv2 pan-cancer AAC 0.084 0.02
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.085 0.02
Download CSV